Systematic Review Sample Work
For further details, please see our website blog and Systematic review manuscript services. How to conduct a systematic review for prospective studies?
A nursing systematic review on mental health and COPD exacerbations
This sample is a systematic review manuscript examining depression and anxiety screening in people with chronic obstructive pulmonary disease (COPD) and its relationship with the frequency and severity of exacerbations. It is written from a nursing perspective for clinicians and researchers in respiratory care, and it follows the conventional sequence of a review article: a structured abstract, an introduction ending in a focused question, methods describing the search, results organised by outcome, a discussion with practice implications, and a section on conclusions and future research.
Why psychological comorbidity matters in COPD
The introduction uses the Global Initiative for Chronic Obstructive Lung Disease (GOLD) definition of COPD as persistent, usually progressive airflow limitation associated with an enhanced inflammatory response to noxious particles or gases. It notes the disease's place among leading causes of death and the burden of exacerbations, which often require antibiotics or corticosteroids and drive hospital use, functional decline and poorer quality of life. Citing earlier work, it reports that anxiety and depression may affect up to 40% of people with COPD and have been linked to more frequent and longer hospitalisations, yet frequently go undiagnosed and untreated. The nursing rationale is holistic: what affects mind, body or spirit affects all three, so assessing mood is part of caring for the whole patient. The review's guiding question asks what effect anxiety and depression screening programmes have on exacerbation frequency and severity in community-dwelling adults with COPD.
Two rounds of searching to find nine studies
The methods are described in enough detail to follow the selection process. Searches between February and March 2017 covered Academic Search Complete, CINAHL with Full Text, Health Source: Nursing/Academic Edition, PsycARTICLES and PsycINFO, for papers published from 1985 to 2017. The first search returned 1,317 records; after limits for outpatient, English-language and peer-reviewed sources, 52 abstracts were screened against inclusion criteria (adults, outpatients, COPD, depression and anxiety) and exclusion criteria (inpatients, asthma, malignancy, heart failure or panic disorder). Because few papers survived, a second search on screening and exacerbations returned 157 records and yielded six more. Reference lists of retrieved papers were also examined. Nine studies were ultimately included, conducted in China, Canada, England, the United States and Spain: five prospective studies, one retrospective study and two meta-analyses, with sample sizes from 116 to 1,134.
What the included studies found
Across 3,426 patients followed for one to three years, six studies linked depression or anxiety with a higher risk of exacerbation. Examples reported in the review include a higher annual exacerbation rate among patients with anxiety or depression (3.81 versus 2.73), a greater proportion experiencing exacerbations (73.5% versus 50.9%), and an odds ratio of 2.28 for exacerbation frequency in one cohort. Anxiety was associated with longer hospital stays when an exacerbation required admission. The review also notes higher depression and anxiety among female patients and higher mortality among depressed patients in several studies. The appraisal is frank about weaknesses: convenience sampling, no power calculations, loss to follow-up, recall bias from monthly telephone contact and predominantly male samples (69% and 75% in two studies).
From association to screening recommendations
Readers should note how the evidence relates to the question. The included studies largely examine the association between psychological symptoms and exacerbations, rather than testing screening programmes directly, and the discussion draws its practice implications from that association. It recommends that anxiety and depression screening become a routine part of COPD assessment, highlights nurses' use of tools such as the PHQ-9 alongside the HADS, BDI and CES-D instruments used in the included studies, and describes nurses' role in patient education. Future research ideas include home-environment studies, health apps for at-home symptom reporting and in-home assessments. This page is a writing sample and does not provide clinical advice.
Building on this review for publication
Authors adapting this structure would usually add a PRISMA flow diagram, a formal risk-of-bias tool, a registered protocol and an updated search, and would either reframe the question around association or seek trials of screening interventions. Literature search and citation support helps with reproducible, multi-database searching, a meta-analysis may be feasible where studies report comparable effect estimates, and a clinical literature review can frame the nursing implications for a practice-focused journal.
Questions about this sample
How many studies and patients were included in this COPD review?
Nine studies were included after two rounds of database searching: five prospective studies, one retrospective study and two meta-analyses. Together they followed 3,426 patients for one to three years, with individual study samples ranging from 116 to 1,134 participants across five countries.
Does the review show that screening for depression reduces COPD exacerbations?
Not directly. The included studies mostly show that depression and anxiety are associated with more frequent exacerbations and, for anxiety, longer hospital stays. The review uses this association to recommend routine screening, but evaluating whether screening itself changes exacerbation outcomes would require studies that test screening programmes.
Which screening instruments are mentioned in the sample?
The included studies used psychiatric interviews and psychometric tools such as the Hospital Anxiety and Depression Scale (HADS), the Beck Depression Inventory (BDI) and the CES-D scale. In discussing nursing practice, the review also refers to the PHQ-9 as a tool nurses can use to identify undetected depression.
What limitations of the evidence does the review identify?
It notes reliance on convenience samples, absence of power analyses, loss to follow-up among patients with severe COPD and depression, possible recall bias from monthly telephone reporting of exacerbations, and predominantly male participant groups. These factors limit how far the findings can be generalised to the wider COPD population.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
